EUVIMEDEUVIMED entdecken
MetaanalyseSystematische Übersicht

Systemic antibiotic treatment for meibomian gland dysfunction—A systematic review and meta‐analysis

Dror Ben Ephraim Noyman, Clara C Chan, Michael Mimouni iD, Margarita Safir iD

Acta Ophthalmologica · 2024

DOI: 10.1111/aos.15681 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Acta Ophthalmologica, 2024. Verfasst von Dror Ben Ephraim Noyman und 3 weiteren Autor:innen. Beteiligte Einrichtung: Ophthalmology Department, Rambam Health Care Campus, Haifa, Israel. Hauptthemen laut MEDLINE: Dry Eye Syndromes, Eyelid Diseases, Meibomian Gland Dysfunction. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To review the efficacy and safety of oral doxycycline antibiotics versus macrolides in the treatment of meibomian gland dysfunction (MGD).

Design

Systematic review and meta‐analysis.

Methods

We performed a systematic search of electronic databases for all peer‐reviewed published studies which included clinical outcomes of oral antibiotic MGD treatment. Individual study data were extracted and evaluated in a weighted pooled analysis, including total sign and symptom scores, meibomian gland secretion score, tear break‐up time (TBUT), fluorescein staining score and rate of complications.

Results

Two thousand nine hundred and thirty‐three studies were found, of which 54 were eligible for the systematic review, and six prospective studies were ultimately included for analysis, reporting on 563 cases from three countries. Age of affected patients ranged between 12 and 90 years. Overall, both treatment methods induced improvement in MGD signs and symptoms. In pooled analysis, macrolides were significantly superior in the total signs score (pooled standardized mean difference (SMD) −0.51, 95% confidence interval (CI): −0.99 to −0.03), meibomian gland secretion score (pooled SMD −0.25, 95%CI: [−0.48, −0.03]), TBUT (SMD −0.31, 95%CI: [−0.50, −0.13]) and fluorescein staining score (SMD −1.01, 95%CI: [−1.72, −0.29]). Moreover, while no severe complications were reported for both treatments, the macrolide group exhibited significantly less adverse events (pooled odds ratio 0.24 with a 95% CI of 0.16 to 0.34).

Conclusions

Both macrolides and tetracyclines are effective treatments for MGD. In this study, macrolides exhibited better efficacy and safety profile compared to tetracyclines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dry Eye SyndromesEyelid DiseasesMeibomian Gland DysfunctionAdolescentAdultAgedAged, 80 and overChildHumansMiddle AgedYoung AdultAnti-Bacterial AgentsDoxycyclineFluoresceinsMacrolidesMeibomian GlandsProspective StudiesTears

Substanzen

Anti-Bacterial AgentsDoxycyclineFluoresceinsMacrolides

Autor:innen und Institutionen

  • Ophthalmology Department, Rambam Health Care Campus, Haifa, Israel.
  • Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada.
  • Ophthalmology Department, Yitzhak Shamir Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

ORCID-Profile: Michael Mimouni, Margarita Safir

Zitieren

APA

Ben Ephraim Noyman, D., Chan, C. C., Mimouni, M., & Safir, M. (2024). Systemic antibiotic treatment for meibomian gland dysfunction—A systematic review and meta‐analysis. Acta Ophthalmologica. https://doi.org/10.1111/aos.15681

Vancouver

Ben Ephraim Noyman D, Chan CC, Mimouni M, Safir M. Systemic antibiotic treatment for meibomian gland dysfunction—A systematic review and meta‐analysis. Acta Ophthalmologica. 2024. doi:10.1111/aos.15681

BibTeX
@article{BenEphraimNoyman2024,
  author = {Ben Ephraim Noyman, Dror and Chan, Clara C and Mimouni, Michael and Safir, Margarita},
  title = {Systemic antibiotic treatment for meibomian gland dysfunction—A systematic review and meta‐analysis},
  journal = {Acta Ophthalmologica},
  year = {2024},
  doi = {10.1111/aos.15681}
}
Kostenlos starten →